OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
3.850
-0.040 (-1.03%)
Aug 25, 2026, 4:00 PM EDT - Market closed
OnKure Therapeutics Employees
OnKure Therapeutics had 45 employees as of December 31, 2025. The number of employees decreased by 1 or -2.17% compared to the previous year.
Employees
45
Change (1Y)
-1
Growth (1Y)
-2.17%
Revenue / Employee
n/a
Profits / Employee
-$1,304,556
Market Cap
155.91M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 45 | -1 | -2.17% |
| Dec 31, 2024 | 46 | -3 | -6.12% |
| Jun 30, 2024 | 50 | - | - |
| Mar 31, 2024 | 49 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Molecular Partners AG | 134 |
| MediWound | 121 |
| Tenaya Therapeutics | 70 |
| Connect Biopharma Holdings | 64 |
| Milestone Pharmaceuticals | 38 |
| Aardvark Therapeutics | 28 |
| Jyong Biotech | 27 |
| Unicycive Therapeutics | 22 |
OKUR News
- 9 days ago - OnKure Therapeutics price target lowered to $14 from $30 at Oppenheimer - TheFly
- 21 days ago - OnKure Therapeutics reports Q2 EPS (31c), consensus (54c) - TheFly
- 21 days ago - OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights - GlobeNewsWire
- 21 days ago - OnKure Therapeutics Slides: Corporate presentation - Filings
- 21 days ago - OnKure Therapeutics Quarterly report: Q2 2026 - Filings
- 21 days ago - OnKure Therapeutics Earnings release: Q2 2026 - Filings
- 5 weeks ago - OnKure Therapeutics price target lowered to $21 from $27 at H.C. Wainwright - TheFly
- 5 weeks ago - OnKure Therapeutics Transcript: KOL event - Transcripts